Download Full Text (510 KB)
Nontuberculous mycobacterial (NTM) disease is a challenge to manage in patients with cystic fibrosis (CF). Diagnosis of NTM pulmonary disease is complex. Effective treatment requires long term, multi-drug therapy delivered by several routes. Consensus recommendations published in 2016 were developed to guide CF providers in NTM screening, diagnosis and management. Primary Outcomes. Children’s Mercy-Kansas City (CMKC) developed an NTM working group to facilitate implementation of standardized NTM management. Methods. NTM working group: Pulmonologist (CF Center Director), Infectious Diseases specialist, nurse practitioner (CF Center Coordinator), and pharmacist. Sought expertise from the Director of Microbiology Laboratory regarding susceptibility testing. Developed NTM Management Guide from guidelines and other available literature. Diagnosis and management algorithm. Medication resource table.
Infectious Disease | Pediatrics | Pharmacy and Pharmaceutical Sciences | Pulmonology
Elson, Claire; Meier, Ellen; Swanson, Douglas; and Oermann, Christopher M., "Implementation Of A Guideline-Based Nontuberculous Mycobacteria Management Algorithm" (2018). Posters. 252.
Infectious Disease Commons, Pediatrics Commons, Pharmacy and Pharmaceutical Sciences Commons, Pulmonology Commons
Presented at the Midwest Cystic Fibrosis Consortium; Iowa City, IA; April 27-28, 2018.